This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (43)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Macular Degeneration  • Articles for Residents  • Alert me on articles by topic

Paul Hahn; Ann H. Milam, PhD; Joshua L. Dunaief, MD, PhD

Arch Ophthalmol. 2003;121:1099-1105.

Objective  To investigate whether iron is involved in the pathogenesis of age-related macular degeneration (AMD).

Methods  Postmortem AMD-affected (nonexudative or exudative) and healthy maculas were studied using the 3,3'-diaminobenzidine–enhanced Perls Prussian blue stain. The Perls Prussian blue stain was quantified by computer-assisted analysis of digital images. To determine whether the iron was chelatable, sections treated with the iron chelator deferoxamine were compared with adjacent, nonchelated sections.

Results  Compared with healthy maculas, AMD-affected maculas had statistically significant increases in the total iron level. Some of this iron was chelatable. The iron was present in retinal pigment epithelium and Bruch's membrane in maculas from patients who had drusen only, geographic atrophy, and exudative AMD in pathologic areas and, occasionally, in relatively healthy areas.

Conclusions  Oxidative stress has been implicated in the pathogenesis of AMD by the Age-Related Eye Disease Study. Increased concentrations of iron, which generate highly reactive hydroxyl radicals via the Fenton reaction, may induce oxidative stress in the macula and lead to AMD. As the increased iron concentrations in AMD-affected eyes consist in part of a chelatable iron pool, treatment of patients who have AMD with iron chelators might be considered a potential therapy. While there are, as yet, no clinical data indicating that the treatment of patients who have AMD with iron chelators is beneficial, data presented herein indicate that further investigation of iron concentrations in postmortem tissues and the mechanisms of iron transport in the retina is warranted.

From the F. M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia. The authors have no relevant financial interest in this article.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Human RPE Melanosomes Protect from Photosensitized and Iron-Mediated Oxidation but Become Pro-oxidant in the Presence of Iron upon Photodegradation
Rozanowski et al.
IOVS 2008;49:2838-2847.
ABSTRACT | FULL TEXT  

Ceruloplasmin/Hephaestin Knockout Mice Model Morphologic and Molecular Features of AMD
Hadziahmetovic et al.
IOVS 2008;49:2728-2736.
ABSTRACT | FULL TEXT  

N-tert-butyl hydroxylamine, a mitochondrial antioxidant, protects human retinal pigment epithelial cells from iron overload: relevance to macular degeneration
Voloboueva et al.
FASEB J. 2007;21:4077-4086.
ABSTRACT | FULL TEXT  

Age-Related Macular Degeneration and Retinal Protein Modification by 4-Hydroxy-2-nonenal
Ethen et al.
IOVS 2007;48:3469-3479.
ABSTRACT | FULL TEXT  

Differential Sensitivity of Cones to Iron-Mediated Oxidative Damage
Rogers et al.
IOVS 2007;48:438-445.
ABSTRACT | FULL TEXT  

Iron Induced Oxidative Damage As a Potential Factor in Age-Related Macular Degeneration: The Cogan Lecture
Dunaief
IOVS 2006;47:4660-4664.
ABSTRACT | FULL TEXT  

Expression and Polarized Localization of the Hemochromatosis Gene Product HFE in Retinal Pigment Epithelium.
Martin et al.
IOVS 2006;47:4238-4244.
ABSTRACT | FULL TEXT  

Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: A model of age-related macular degeneration
Imamura et al.
Proc. Natl. Acad. Sci. USA 2006;103:11282-11287.
ABSTRACT | FULL TEXT  

Retinal localization and copper-dependent relocalization of the Wilson and menkes disease proteins.
Krajacic et al.
IOVS 2006;47:3129-3134.
ABSTRACT | FULL TEXT  

The Iron Carrier Transferrin Is Upregulated in Retinas from Patients with Age-Related Macular Degeneration
Chowers et al.
IOVS 2006;47:2135-2140.
ABSTRACT | FULL TEXT  

Strong Labeling for Iron and the Iron-Handling Proteins Ferritin and Ferroportin in the Photoreceptor Layer in Age-Related Macular Degeneration
Dentchev et al.
Arch Ophthalmol 2005;123:1745-1746.
FULL TEXT  

(R)-{alpha}-Lipoic Acid Protects Retinal Pigment Epithelial Cells from Oxidative Damage
Voloboueva et al.
IOVS 2005;46:4302-4310.
ABSTRACT | FULL TEXT  

Iron alters glutamate secretion by regulating cytosolic aconitase activity
McGahan et al.
Am. J. Physiol. Cell Physiol. 2005;288:C1117-C1124.
ABSTRACT | FULL TEXT  

Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration
Hahn et al.
Proc. Natl. Acad. Sci. USA 2004;101:13850-13855.
ABSTRACT | FULL TEXT  

Association of Drusen Deposition with Choroidal Intercapillary Pillars in the Aging Human Eye
Lengyel et al.
IOVS 2004;45:2886-2892.
ABSTRACT | FULL TEXT  

From the Library
Br. J. Ophthalmol. 2004;88:316-316.
FULL TEXT